1650611720 1_nyx22ygs

Sean C. has taken KESIMPTA® and has been compensated for his time.

Individual results may vary.

MY EXPERIENCE

quotesHello, I'm Sean! I'm a high school science teacher living in Oregon with my daughter. Since my RMS diagnosis in 2004, it has been important to me to find support in the MS community. I've participated in bike ride fundraiser events, and I'm even planning a trip with some RMS pals! I started KESIMPTA in 2020.

It Gets Better

I feel grateful that I've come a long way since my initial diagnosis. When I was first told I have RMS in 2004, it felt like my entire life took a turn for the worse. I questioned my future, and it was such a big psychological shift on top of physical symptoms. Not long after the diagnosis, my wife and I got divorced. I went through some dark times, but I want to share my comeback story to help inspire others. My favorite saying is from a Swahili phrase that means "slow and steady," and I believe that if you just keep moving forward toward your goals, slow and steady, you'll make it there.

Finding Motivation

I feel motivated by my students. During my earlier career in the tech industry, I had the opportunity to try my hand at teaching. I liked it so much I decided to make the switch to do it full time. It's so fulfilling for me to feed these kids with knowledge and help them take steps towards their goals. My daughter is my biggest inspiration. I want to be the best and healthiest person I can be for her. She's starting to look at colleges and wants to go out of state. I'll miss her like crazy, but I'm so proud of her for wanting to expand her horizons.

Importance of Emotional Support

I didn't expect the impact the RMS community has had on my life. I've found support through people locally and online, and it has added so much value to my life. I participate in RMS bike rides and am involved in RMS Facebook groups. I have a close group of friends with RMS, and we're planning on going on vacation together to the Himalayas. I love traveling and climbing, so I'm really pumped about this future trip. The emotional support is just as important as getting on the right treatment choice for you. It's amazing what can happen by putting yourself out there.

Simply Starting

When I took my first dose of KESIMPTA, I felt well prepared. I had gotten a call from my AlongsideTM Coordinator beforehand explaining all about KESIMPTA—the starter doses, what to expect, the delivery, and more. When it came to actually starting, everything was all set. My Coordinator had helped me with insurance approvals and co-pay assistance. And once I watched the supplemental injection training videos online,* I didn't have any questions! I felt confident and comfortable knowing my Coordinator was there for me and that he truly wanted me to have a positive experience with KESIMPTA.

My Positive Outlook

My favorite part about KESIMPTA is...everything! Having a background in biochemistry, I was excited about the idea of a B-cell therapy with subcutaneous delivery. So I asked my doctor about it when it first came out. But honestly, it checks all the boxes for me. The convenience of at-home treatment is fantastic. So far, going to my MRI scans has been less scary and things are looking up! quotes

*Your doctor is the best person to show you how to take KESIMPTA. The Alongside injection training is only meant to supplement their instructions.

Ananda image

Ananda is a passionate nurse who also needs to take care of herself
and her RMS.

VIEW ANANDA'S STORY BACK TO KESIMPTA STORIES

Ananda is a passionate nurse who also needs to take care of herself and her RMS.

VIEW ANANDA'S STORY BACK TO KESIMPTA STORIES

Get the results of the head-to-head studies vs AUBAGIO® (teriflunomide).

SEE THE RESULTS

Take a look at commonly
asked questions.

GET SOME ANSWERS
email

Looking for help navigating life with RMS?

Let us bring you personalized resources.
Sign Up

email

Looking for help navigating
life with RMS?

Let us bring you
personalized resources.

Sign Up

phone

Pay as little as $0 co-pay† & enroll in the
Alongside™ KESIMPTA Support Program.

Learn More

phone

Pay as little as $0 co-pay† &
enroll in the Alongside™
KESIMPTA Support Program.

Learn More

MRI, magnetic resonance imaging; MS, multiple sclerosis; RMS, relapsing multiple sclerosis.

†Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Patients with commercial insurance and an initial denial of coverage may receive up to 12 months of free product while coverage is pursued. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions at start.kesimpta.com.

+

-

IMPORTANT SAFETY INFORMATION

Who should not take KESIMPTA?

Do NOT take KESIMPTA if you:

  • have an active hepatitis B virus (HBV) infection.

  • have had an allergic reaction to ofatumumab or life-threatening

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS)

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple

IMPORTANT SAFETY INFORMATION & INDICATION

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting disease, and active secondary progressive disease.

It is not known if KESIMPTA is safe or effective in children.

IMPORTANT SAFETY INFORMATION

Who should not take KESIMPTA?

Do NOT take KESIMPTA if you:

  • have an active hepatitis B virus (HBV) infection.

  • have had an allergic reaction to ofatumumab or life-threatening injection-related reaction to KESIMPTA.

What is the most important information I should know about KESIMPTA?

KESIMPTA can cause serious side effects such as:

  • Infections. Serious infections, which can be life-threatening or cause death, can happen during treatment with KESIMPTA. If you have an active infection, your health care provider (HCP) should delay your treatment with KESIMPTA until your infection is gone. KESIMPTA taken before or after other medicines that weaken the immune system may increase your risk of getting infections. Tell your HCP right away if you have any infections or get any symptoms including painful and frequent urination, nasal congestion, runny nose, sore throat, fever, chills, cough, or body aches.

INDICATION

What is KESIMPTA (ofatumumab) injection?

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting disease, and active secondary progressive disease.

It is not known if KESIMPTA is safe or effective in children.

  • HBV reactivation. If you have ever had HBV infection, it may become active again during or after treatment with KESIMPTA (reactivation). If this happens, it may cause serious liver problems including liver failure or death. Before starting KESIMPTA, your HCP will do a blood test to check for HBV. They will also continue to monitor you during and after treatment with KESIMPTA for HBV. Tell your HCP right away if you get worsening tiredness or yellowing of your skin or the white part of your eyes.

  • Progressive Multifocal Leukoencephalopathy (PML). PML may happen with KESIMPTA. PML is a rare, serious brain infection caused by a virus that may get worse over days or weeks. PML can result in death or severe disability. Tell your HCP right away if you have any new or worsening neurologic signs or symptoms. These may include weakness on one side of your body, loss of coordination in arms and legs, vision problems, changes in thinking and memory, which may lead to confusion and personality changes.

  • Weakened immune system. KESIMPTA taken before or after other medicines that weaken the immune system could increase your risk of getting infections.

Before you take KESIMPTA, tell your HCP about all your medical conditions, including if you:

  • Have or think you have an infection including HBV or PML.

  • Have ever taken, currently take, or plan to take medicines that affect your immune system. These medicines could increase your risk of getting an infection.

  • Have had a recent vaccination or are scheduled to receive any vaccinations.

    • You should receive any required 'live' or 'live-attenuated' vaccines at least 4 weeks before you start treatment with KESIMPTA. You should not receive 'live' or 'live-attenuated' vaccines while you are being treated with KESIMPTA and until your HCP tells you that your immune system is no longer weakened.

    • Whenever possible, you should receive any 'non-live' vaccines at least 2 weeks before you start treatment with KESIMPTA.

    • Talk to your HCP about vaccinations for your baby if you used KESIMPTA during your pregnancy.

  • Are pregnant, think that you might be pregnant, or plan to become pregnant. It is not known if KESIMPTA will harm your unborn baby. Females who can become pregnant should use birth control (contraception) during treatment with KESIMPTA and for 6 months after your last treatment. Talk with your HCP about what birth control method is right for you during this time.

  • Are breastfeeding or plan to breastfeed. It is not known if KESIMPTA passes into your breast milk. Talk to your HCP about the best way to feed your baby if you take KESIMPTA.

Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use KESIMPTA?

See the detailed Instructions for Use that comes with KESIMPTA for information about how to prepare and inject a dose of KESIMPTA and how to properly throw away (dispose of) used KESIMPTA Sensoready pens or prefilled syringes.

  • Use KESIMPTA exactly as your HCP tells you to use it.

  • Your HCP will show you how to prepare and inject KESIMPTA the right way before you use it for the first time.

  • Do not inject into areas where the skin is tender, bruised, red, scaly or hard. Avoid areas with moles, scars, or stretch marks.

KESIMPTA may cause serious side effects including:

  • Injection-related reactions. Injection-related reactions are a common side effect of KESIMPTA. Injecting KESIMPTA can cause injection-related reactions that can happen within 24 hours (1 day) following the first injections and with later injections. There are two kinds of reactions:

    • at or near the injection site: redness of the skin, swelling, itching, and pain. Talk to your HCP if you have any of these signs and symptoms.

    • that may happen when certain substances are released in your body: fever, headache, pain in the muscles, chills, tiredness, rash, hives, trouble breathing, swelling of the face, eyelids, lips, mouth, tongue and throat, and feeling faint, or chest tightness. Contact your HCP right away if you experience any of these signs and symptoms, especially if they become worse or you have new severe signs of reactions after subsequent injections. It could be a sign of an allergic reaction, which can be serious.

  • Low immunoglobulins. KESIMPTA may cause a decrease in some types of antibodies. Your HCP will do blood tests to check your blood immunoglobulin levels.

The most common side effects of KESIMPTA include:

  • Upper respiratory tract infection, with symptoms such as sore throat and runny nose, and headache.

  • Headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information including Medication Guide.

KESIMPTA, the KESIMPTA logo, and SENSOREADY are registered trademarks of Novartis AG.

ALONGSIDE and the ALONGSIDE logo are trademarks of Novartis AG.

AUBAGIO is a registered trademark of Genzyme, a Sanofi company.

Please see each product's respective PI for additional information including indication, dosing, and safety.